Urinary Incontinence Device Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product, Category, Incontinence Type and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030.

The global urinary incontinence device market was valued at $2,098.65 million in 2020, and is projected to reach $6,179.32 million by 2030, registering a CAGR of 11.8% from 2021 to 2030. Any involuntary urine leakage is referred to as incontinence. A broken sphincter or a malfunctioning bladder are the most common causes of male urinary incontinence. The sphincter is a circular muscle in the bladder that regulates urine flow. When this muscle is injured, it loses its ability to squeeze and seal the urethra, the tube that transports urine from the bladder to the outside of the body. Urinary incontinence devices assist in the collection and retention of urine and aid in the effective management of urinary incontinence. Urinary incontinence causes uncontrollable urine leakage.  

Increase in prevalence of urological disorders and development of advanced urinary incontinence device boost the growth of urinary incontinence device market. In addition, the rise in demand for minimally invasive operations, as well as an aging population that is more prone to urological problems drive the growth of the urinary incontinence device market. Furthermore, the number of urinary incontinent patients switching from traditional methods is expected to rise in the near future. The expansion of the market is aided by the increase in risk of associative urological disorders among people. However, the growth of the urinary incontinence device market is hampered by a lack of awareness about new improvements in urinary incontinence devices and post-operative difficulties linked with the devices. Furthermore, rise in healthcare spending in developing nations is expected to open up new growth opportunities.

The outbreak of COVID-19 has disrupted workflows in the health care sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care The overall impact of the COVID-19 pandemic remained negative for key players in the urinary incontinence industry. Outpatient clinics for female urinary incontinence, benign prostatic hyperplasia, infertility, and sexual medicine, benign scrotal conditions, renal stone, and bladder stone were most affected, according to a 2020 research study by Jeremy Yuen-Chun Teoh et al. titled 'A Global Survey on the Impact of COVID-19 on Urological Services. Moreover, during the COVID-19 pandemic 2020, there was a significant reduction in many types of outpatient tests and treatments, with surgical treatments for female urinary incontinence, infertility, kidney stones, and bladder stones having the greatest rates of cut-down services. Furthermore, due to COVID, several market players experienced a revenue drop in the urology platform. For instance, In the fiscal year 2019-20, Coloplast Corp.'s interventional urology segment experienced negative organic growth of -7 percent. The drop in sales of Altis single-incision slings and other goods was mostly due to the cancellation of elective operations and treatments in the United States as a result of the COVID-19 outbreak. Moreover, the elective procedures outside the U.S. were also postponed in several countries, due to the COVID-19 outbreak.

Urinary Incontinence Devices Market Segmentation  

The urinary incontinence devices market is segmented into product, category, incontinence type, end user, and region. By product, the market is divided into urinary catheters, vaginal slings, electrical stimulation devices, artificial urinary sphincters, and other devices. The urinary catheters further bifurcated into Foley catheters and other urinary catheters. Whereas, vaginal slings sub segmented into conventional vaginal slings and advanced vaginal slings. By category, it is classified into external urinary incontinence devices and internal urinary incontinence devices. By incontinence type, it is classified into stress incontinence, urge incontinence, overflow incontinence, and functional incontinence. By end user, it is divided into hospitals, clinics, and other. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review

By product, the vaginal slings segment currently dominates the global urinary incontinence device market and is expected to continue during the forecast period. High contribution of the conventional vaginal slings in the vaginal slings market owing to high preference for the use of biomaterials in surgical treatment of incontinence drive growth of the market. Advancements in the conventional vaginal slings assist in eliminating the post-operative complications associated with the vaginal sling surgeries and several key players are developing conventional vaginal slings using advanced synthetic materials to meet the requirements of the patient. These factors boost the urinary incontinence device market growth.

By category, the internal urinary incontinence device segment generated the highest revenue in 2020 and is anticipated to continue this trend throughout the forecast period. This is attributed to the increase in focus on the development of vaginal slings along with rise in demand for internal urethral devices.

By incontinence type, the stress urinary incontinence (SUI) segment dominates the global urinary incontinence devices market. This is attributed to high incidence of stress urinary incontinence witnessed among women globally. The epidemiological studies on the stress urinary incontinence in women have concluded that approximately 50% of women with urinary incontinence report symptoms of stress incontinence.

By end user, the hospital segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period owing to urinary incontinence most commonly affects women and the prevalence is high among hospitalized older adults. Thus, the hospital segment has displayed maximum adoption of the urinary incontinence devices as large patient pool suffering from chronic conditions or pregnancy are associated with urinary incontinence.

Snapshot of the Asia-Pacific Urinary Incontinence Device Market  

Asia-Pacific is expected to exhibit the fastest growth rate during the forecast period. The region offers lucrative opportunities for players that operate in the urinary incontinence devices market due to its high population base, growth in disposable incomes, and improvement in patient awareness about advanced urinary incontinence management. Japan, India, and China are among the leading countries for prevalence of urinary incontinence in Asia-Pacific, which further contributes toward the robust growth displayed by this region in the global urinary incontinence device market. In addition, changes in lifestyle and demographic changes have led to increase in the cases of gynecological problems in females at a younger age. Moreover, increase in the number of hysterectomy cases, rise in number of women with early onset of menopause, and increase in obese population propel the market growth in this region as women suffering from aforementioned health conditions are more susceptible to urinary incontinence.

The key players in this market have adopted product launch as one of their key developmental strategies such as acquisitions and product launches. The major companies profiled in this report include Becton, Dickinson and Company (C.R. Bard Inc.), Boston Scientific Corporation, Caldera Medical, Coloplast A/S, ConvaTec Group plc, Cook Group Inc. (Cook Medical Inc.), Johnson & Johnson (Ethicon Inc.), Laborie Medical (Cogentix Medical Inc.), Medtronic plc, and Teleflex Incorporated.

Key Benefits For Stakeholders

• The study provides an in-depth analysis of the global urinary incontinence device market along with the current trends and future estimations to explain the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2020 to 2028 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the application and products of urinary incontinence used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the urinary incontinence device market.

  Urinary Incontinence Device Market Report Highlights

Aspects	Details
By Product	Urinary Catheters Foley Catheters Other Urinary Catheters Vaginal Slings Conventional Vaginal slings Advanced Vaginal Slings Electrical Stimulation Devices Artificial Urinary Sphincters Other Devices
By CATEGORY	External Urinary Incontinence Devices Internal Urinary Incontinence Devices
By Incontinence Type	Stress urinary incontinence Urge urinary incontinence Overflow urinary incontinence Functional urinary incontinence
By End User	Hospitals Clinics Other
By Region	North America  (U.S., Canada, Mexico) Europe  (UK, France, Germany, Spain, Rest of Europe) Asia-Pacific  (Japan, China, India, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, Turkey, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Coloplast A/S, Laborie Medical (Cogentix Medical Inc.), Caldera Medical, Boston Scientific Corporation, Johnson & Johnson (Ethicon Inc.), Teleflex Incorporated, Becton, Dickinson and Company (C.R. Bard Inc.), Cook Group Inc. (Cook Medical Inc.), ConvaTec Group plc, Medtronic plc

Analyst Review

The utilization of urinary incontinence devices is projected to witness a significant rise with growth in number of incontinent patients across the globe. The urinary incontinence devices market is largely fragmented, and bargaining power of suppliers clearly varies in patient centric medical app devices and patient centric medical app services market. Technological innovation is turning out to be a principal strategy to increase bargaining power of buyers. 

The urinary incontinence devices market has piqued the interest of healthcare professionals, patients, and surgeons owing to improved care of patients suffering from involuntary urine leakage. There have been remarkable technological advancements in the development of novel urinary incontinence devices including mini-slings, single-incision slings, advanced catheters, and electrical stimulation devices. As the market is growing at a steady rate in the developed nations, Asia-Pacific and LAMEA are expected to offer high growth opportunities to the key players in this market. In addition, patients suffering from chronic ailments such as multiple sclerosis, Parkinson's disease, a stroke, a brain tumor, and spinal injury are affected by associated urinary incontinence. This offers large patient pool suffering from incontinence demanding development of novel devices for the management of the same.

Rise in demand for surgical treatment of urinary incontinence targeted toward early cure, and increase in geriatric population with high risk of urinary incontinence is set to propel the market growth. Moreover, rise in the research activities to exploit the advantages offered by urinary incontinence devices and surge in healthcare expenditures in developing countries offer lucrative opportunities for the market growth.
 

Author Name(s) : Kishor Sherkar| Monika Darandale | Roshan Deshmukh

Related Tags

• Implantable Devices
• Disposable Medical Supplies
• Assistive Devices
• Nonwoven Medical Products
• Catheter
• Disposable Medical Suppies